Featured Posts
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Search Posts
Op-Eds
Give Nestlé a Break
Generally, the European left has no love for big American financial firms. But some Swiss shareholder activists have embraced the U.S.’s largest proxy-advisory service in…
Washington Post
Painkiller Decision suggest shift in FDA’s risk-benefit equation
Op-Eds
Nation Descends into Mercury Madness
Mercury is all over the news these days, which is appropriate for an element named after the messenger of the gods. At some Maryland high…
Citation
Americans told fish tales about mercury hazards in fish consumption
Products
The Drug Reimportation Controversy
As policy battles go, the drug reimportation debate is an unusual one. On its face, the federal ban on reimporting pharmaceuticals appears to violate the…
CEI Planet
February/ March Issue of CEI’s Monthly Planet
Full Document Available in PDF Featured in the February/March Issue of the…